» Articles » PMID: 31408238

Understanding and Leveraging Cell Metabolism to Enhance Mesenchymal Stem Cell Transplantation Survival in Tissue Engineering and Regenerative Medicine Applications

Overview
Journal Stem Cells
Date 2019 Aug 14
PMID 31408238
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

In tissue engineering and regenerative medicine, stem cell-specifically, mesenchymal stromal/stem cells (MSCs)-therapies have fallen short of their initial promise and hype. The observed marginal, to no benefit, success in several applications has been attributed primarily to poor cell survival and engraftment at transplantation sites. MSCs have a metabolism that is flexible enough to enable them to fulfill their various cellular functions and remarkably sensitive to different cellular and environmental cues. At the transplantation sites, MSCs experience hostile environments devoid or, at the very least, severely depleted of oxygen and nutrients. The impact of this particular setting on MSC metabolism ultimately affects their survival and function. In order to develop the next generation of cell-delivery materials and methods, scientists must have a better understanding of the metabolic switches MSCs experience upon transplantation. By designing treatment strategies with cell metabolism in mind, scientists may improve survival and the overall therapeutic potential of MSCs. Here, we provide a comprehensive review of plausible metabolic switches in response to implantation and of the various strategies currently used to leverage MSC metabolism to improve stem cell-based therapeutics.

Citing Articles

Genetic enhancement: an avenue to combat aging-related diseases.

Cai Y, Ji Z, Wang S, Zhang W, Qu J, Belmonte J Life Med. 2025; 1(3):307-318.

PMID: 39872744 PMC: 11749557. DOI: 10.1093/lifemedi/lnac054.


Machine Learning and Metabolomics Predict Mesenchymal Stem Cell Osteogenic Differentiation in 2D and 3D Cultures.

Klontzas M, Vernardis S, Batsali A, Papadogiannis F, Panoskaltsis N, Mantalaris A J Funct Biomater. 2024; 15(12).

PMID: 39728167 PMC: 11680063. DOI: 10.3390/jfb15120367.


Mesenchymal Stromal Cells for Aging Cartilage Regeneration: A Review.

Wu K, Chang Y, Ding D, Lin S Int J Mol Sci. 2024; 25(23.

PMID: 39684619 PMC: 11641625. DOI: 10.3390/ijms252312911.


GPC3-mediated metabolic rewiring of diabetic mesenchymal stromal cells enhances their cardioprotective functions via PKM2 activation.

Joladarashi D, Thej C, Mallaredy V, Magadum A, Cimini M, Gonzalez C iScience. 2024; 27(10):111021.

PMID: 39429777 PMC: 11490746. DOI: 10.1016/j.isci.2024.111021.


Role of Mesenchymal Stem/Stromal Cells (MSCs) and MSC-Derived Extracellular Vesicles (EVs) in Prevention of Telomere Length Shortening, Cellular Senescence, and Accelerated Biological Aging.

Arellano M, VanHeest M, Emmadi S, Abdul-Hafez A, Ibrahim S, Thiruvenkataramani R Bioengineering (Basel). 2024; 11(6).

PMID: 38927760 PMC: 11200821. DOI: 10.3390/bioengineering11060524.